1,000
Participants
Start Date
April 6, 2023
Primary Completion Date
October 15, 2026
Study Completion Date
April 15, 2027
SAINT® Neuromodulation System (NMS)
The SAINT® NMS utilizes a type of accelerated iTBS delivered to a personalized treatment target derived from a functional MRI scan. SAINT® was designed to optimize the individual patient response to treatment. This novel approach to TMS is accomplished by focusing on three critical aspects of the treatment that drive effect. These aspects are personalized stimulation target, total course dose of stimulation, and neurophysiologically relevant stimulation pattern.
Fermata, Brooklyn
LA TMS, Los Angeles
BrainHealth Solutions, Costa Mesa
Integral TMS, Sunnyvale
Acacial Research Center, Sunnyvale
Seattle Neuropsychiatric Treatment Center, Seattle
Boston Precision Neurotherapeutics, Natick
Lead Sponsor
Magnus Medical
INDUSTRY